Literature DB >> 22385375

Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline.

Jessica M Foley1, Mark L Ettenhofer, Michelle S Kim, Nina Behdin, Steven A Castellon, Charles H Hinkin.   

Abstract

The present study examined the impact of cognitive reserve in maintaining intact neuropsychological (NP) function among older HIV-positive individuals, a uniquely at-risk subgroup. Participants included 129 individuals classified by HIV serostatus, age group, and NP impairment. A three-way analysis of variance (ANOVA) followed by a series of within-group ANOVA and multiple regression analyses were conducted to investigate the pattern of cognitive reserve (vs. other protective) influence among groups with varying risks of NP impairment. Results indicated a significant age × HIV status interaction, with older HIV-positive individuals demonstrating higher cognitive reserve than subgroups with less risk for NP compromise (younger age and/or HIV-negative). Results demonstrated higher cognitive reserve specific to NP-intact older HIV-positive individuals. Within this group, the interaction of younger age and higher cognitive reserve independently contributed to cognitive status when controlling for psychiatric, immunological, and psychosocial protective mechanisms, suggesting the importance of cognitive reserve beyond other protective mechanisms in maintaining optimal NP functioning in those individuals most at risk. Alongside younger age, factors contributing to cognitive reserve (i.e., education and estimated premorbid intelligence) may provide substantial benefit for older HIV-positive adults who are at high risk for NP compromise.

Entities:  

Mesh:

Year:  2012        PMID: 22385375      PMCID: PMC3638954          DOI: 10.1080/09084282.2011.595601

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  27 in total

Review 1.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

Review 2.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 3.  Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality.

Authors:  K Goodkin; F L Wilkie; M Concha; C H Hinkin; S Symes; T T Baldewicz; D Asthana; R K Fujimura; D Lee; M H van Zuilen; I Khamis; P Shapshak; C Eisdorfer
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.

Authors:  M Pereda; J L Ayuso-Mateos; A Gómez Del Barrio; S Echevarria; M C Farinas; D García Palomo; J González Macias; J L Vázquez-Barquero
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

5.  Human immunodeficiency virus infection in elderly patients.

Authors:  A A Butt; K K Dascomb; K B DeSalvo; L Bazzano; P J Kissinger; H M Szerlip
Journal:  South Med J       Date:  2001-04       Impact factor: 0.954

Review 6.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

7.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

8.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Authors:  James T Becker; Oscar L Lopez; Mary Amanda Dew; Howard J Aizenstein
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  White matter hyperintensities and cognition: testing the reserve hypothesis.

Authors:  Adam M Brickman; Karen L Siedlecki; Jordan Muraskin; Jennifer J Manly; José A Luchsinger; Lok-Kin Yeung; Truman R Brown; Charles DeCarli; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2009-11-18       Impact factor: 4.673

10.  Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.

Authors:  Jim Young; Sabina De Geest; Rebecca Spirig; Markus Flepp; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Bernard Hirschel; Amalio Telenti; Pietro Vernazza; Manuel Battegay; Heiner C Bucher
Journal:  BMJ       Date:  2004-01-03
View more
  22 in total

1.  Cognitive reserve protects against apathy in individuals with human immunodeficiency virus.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Deena Peyser; Barry S Zingman; Joe Verghese
Journal:  Arch Clin Neuropsychol       Date:  2013-09-09       Impact factor: 2.813

Review 2.  Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve.

Authors:  Daniel Barulli; Yaakov Stern
Journal:  Trends Cogn Sci       Date:  2013-09-07       Impact factor: 20.229

3.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

Review 4.  Brain and cognitive reserve: Translation via network control theory.

Authors:  John Dominic Medaglia; Fabio Pasqualetti; Roy H Hamilton; Sharon L Thompson-Schill; Danielle S Bassett
Journal:  Neurosci Biobehav Rev       Date:  2017-01-16       Impact factor: 8.989

5.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

6.  Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Authors:  Laura M Campbell; Christine Fennema-Notestine; Rowan Saloner; Mariam Hussain; Anna Chen; Donald Franklin; Anya Umlauf; Ronald J Ellis; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; J Allen McCutchan; Scott Letendre; Igor Grant; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2019-10-02       Impact factor: 2.892

7.  Genetic variation in alcohol dehydrogenase is associated with neurocognition in men with HIV and history of alcohol use disorder: preliminary findings.

Authors:  Rowan Saloner; Emily W Paolillo; Maulika Kohli; Sarah S Murray; David J Moore; Igor Grant; Mariana Cherner
Journal:  J Neurovirol       Date:  2020-01-13       Impact factor: 2.643

8.  Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.

Authors:  Yingying Ding; Haijiang Lin; Weiwei Shen; Qionghai Wu; Meiyang Gao; Na He
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-03       Impact factor: 4.147

9.  HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.

Authors:  Jasmina Boban; Dusko Kozic; Vesna Turkulov; Jelena Ostojic; Robert Semnic; Dajana Lendak; Snezana Brkic
Journal:  Eur Radiol       Date:  2017-03-14       Impact factor: 5.315

10.  Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Authors:  David E Vance; Graham J McDougall; Natalie Wilson; Marcus Otavio Debiasi; Shameka L Cody
Journal:  Top Geriatr Rehabil       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.